ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 19 of 46
Up
УЖМБС 2022, 7(1): 144–149
https://doi.org/10.26693/jmbs07.01.144
Clinical Medicine

The Peculiarities of Some Indices of Hemostasis System Changes in the Patients with Chronic Cor Pulmonale of Broncho-Pulmonary Genesis during Decompensation Stage and in Conditions of its Comorbidity with Hypertensive Disease

Petrov Ye. Ye. 1, Burmak Yu. G. 2, Treumova S. I. 1, Ivanytska T. A. 1, Savchuk T. A. 3
Abstract

The purpose of the study is to research and analyze the peculiarities of some indices of hemostasis system changes and define their possible role in the formation of a vascular lesion in the patients with chronic cor pulmolale of broncho-pulmonary genesis during decompensating stage and in conditions of its comorbidity with hypertensive disease. Materials and methods. The retrospective study and analysis of indices of hemostasis system (platelet count, thrombin time, prothrombin time, antithrombin - III, plasma tolerance to heparin, plasmin lysis, fibrinogen, soluble fibrin) in 96 patients with chronic obstructive pulmonary disease and decompensated chronic cor pulmolale with signs of circulatory insufficiency of the 2nd stage (female – 34, male – 62, mean age – 57.5±1.2) were carried out. 32 patients with the isolated pathology formed the comparative group whereas 64 patients with the comorbid hypertensive disease of the 2nd stage, of the 2nd degree of arterial hypertension, built the main group. The obtained research results of the patients of the main and comparative groups were compared both in groups and with the indices of practically healthy individuals (n = 15) of the same gender and age. Results and discussion. The obtained results indicated to a certain extent the presence of a significant increase of coagulation potential, an increase of fibrinolysis system activity and the disorder of “external way” of blood coagulation. It doesn’t exclude the change of procoagulant factors content/activity and can be considered as a result of their intensive using. The foregoing changes were the most significant (it concerns all indices) in the patients with chronic cor pulmolale and comorbid hypertensive disease. Our results confirm to a certain extent the following idea of scientists. Hypercoagulation and activation of the platelets together with the chronic systemic inflammation and oxidative stress are general pathogenic mechanisms of chronic obstructive pulmonary disease and cardiovascular diseases, particularly of the arterial hypertension. It is reflected clearly as a very important constituent part of “mutual burden” syndrome in case of a comorbid course. Conclusion. The peculiarity of the hemostasis system changes in patients with decompensated chronic cor pulmolale of broncho-pulmonary genesis is an increase of its coagulation potential; the most significant its manifestations with activation and simultaneous suppression of fibrinolytic activity are typical of the patients with the comorbid hypertensive disease (it can be considered as manifestations of the chronic disseminated intervascular coagulation syndrome). The increased coagulation potential of a hemostasis system in the patients with decompensated chronic cor pulmolale of broncho-pumonary genesis should be considered as a marker of the risk of the thrombogenic vascular complications development; it is necessary to carry out the periodical monitoring of its indices with the purpose of prevention of the development of cardiovascular events both in the isolated course of chronic cor pulmolale and in the conditions of comorbidity with hypertensive disease

Keywords: chronic cor pulmonale, hypertensive disease, comorbidity, hemostasis system

Full text: PDF (Ukr) 257K

References
  1. Mostovoy YuM. Khronichne obstruktyvne zakhvoryuvannya lehen. Klyuchovi pytannya [Chronic obstructive pulmonary disease. The key questions]. Ukr Med Chasopys.2016 Serp 25;4(114):63-5. [Ukrainian]
  2. Konoplova LF, Rudenko YuV. Khronichne leheneve sertse [Chronic cor pulmonale]. U kn: Amosova KM, Red. Vnutrishnya medytsyna. K: Medytsyna; 2009; 2: 158-78. [Ukrainian]
  3. Pavlov P, Ivanov Y, Glogovska P, Popova T, Borisova E, Nozharov V. Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease. Eur Respir J. 2012 Sep 1;40(56):986.
  4. Berezin AYe. Khronicheskaya obstruktivnaya bolezn legkikh i kardiovaskulyarnyy risk [Chronic obstructive pulmonary disease and cardiovascular risk]. Ukr Med Chasopys. 2009; 2(70):62-9. [Russian]
  5. Caughey GE, Ramsay EN, Vitry AI, Gilbert AL, Luszcz MA, Ryan P, et al. Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study. J Epidemiol Community Health. 2010 Dec; 64(12):1036-42. PMID: 19854745. https://doi.org/10.1136/jech.2009.088260
  6. Chandy D, Aronow WS, Banach M. Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease. Itegr Blood Press Control. 2013;6:101-9. PMID: 23901294. PMCID: PMC3724277. https://doi.org/10.2147/IBPC.S33982
  7. Petrov YeYe, Burmak YuG, Treumova SI, Ivanytsʹka TA. Porivnyalʹna kharakterystyka deyakykh pokaznykiv systemy hemostazu u khvorykh na kompensovane khronichne leheneve sertse bronkho-lehenevoho genezu ta v umovakh yoho komor bidnosti z hipertonichnoyu khvoroboyu [Comparative characteristics of some hemostasis system indices in the patients with compensated chronic cor pulmonale of broncho-pulmonary genesis and in conditions of its comorbidity with hypertensive disease]. Visnyk problem biolohiyi i medytsyny. 2021;1(159):109-12. [Ukrainian]. https://doi.org/10.29254/2077-4214-2021-1-159-109-112
  8. Nakaz MOZ Ukrayiny vid 27 chervnya 2013 №555. Khronichne obstruktyvne zakhvoryuvannya leheni. Adaptovana klinichna nastanova, zasnovana na dokazakh [Chronic obstructive pulmonary disease. Adapted evidence-based clinical guideline]. [Ukrainian]. Available from: http://mtd.dec.gov.ua/images/dodatki/2013_555_HOZL/2013_555_hozl_kn.pdf
  9. Feshchenko YuI, Gavrysyuk VK, Dzyublyk OYa, Mostovoy YuM, Pertseva TO, Polyanska MO, ta in. Adaptovana klinichna nastanova: khronichne obstruktyvne zakhvoryuvannya lehen [Adapted clinical guideline: chronic obstructive pulmonary disease] Ukr Pulmon Zh. 2020;3:5-36. [Ukrainian]. https://doi.org/10.31215/2306-4927-2020-109-3-5-36
  10. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2020 report. 2020. Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINALver1.2-03Dec19_WMV.pdf
  11. Gavrysyuk VK. Khronycheskoye legochnoye serdtse. [Chronic cor pulmonale] Praktychna angiologiya.2008;4(15). [Russian]. Avaiable from: https://angiology.com.ua/ua/archive/2008/4%2815%29/article-155/hronicheskoe-legochnoe-serdce-
  12. Nastanova ta klinichnyy protokol nadannya medychnoyi dopomohy «Arterialna hipertenziya» [Guideline and clinical protocol of medical care «Arterial hypertension»]. K; 2012. 107 s. [Ukrainian]
  13. Mancia G, Fagard R, Narkiewicy K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Eur Heart J. 2013 Jul 21;34(28):2159-219. PMID: 23771844. https://doi.org/10.1093/eurheartj/eht151
  14. Chesnikova AI. Osobennosti sostoyaniya sistemy gemostaza na etapakh razvitiya i progressirovaniya khronicheskogo legochchnogo serdtsa [Hemostasis at various stages of chronic pulmonary heart development]. Kardiovaskulyarnaya terapiya i profilaktika. 2006;5(2):50-56. [Russian]
  15. Samoylova SO, Plyenova OM, Shkala LV. Analiz zmin systemy zhortannya krovi u khvorykh na hipertonichnu khvorobu v poyednanni z khronichnym obstruktyvnym zakhvoryuvannyam lehenʹ riznoho stupenya vazhkosti [The analysis of blood coagulation system’s changes in the patients with hypertensive disease in combination with chronic cor pulmonale of different degree severity]. ScienceRise. Medical science. 2017;4:41-5. [Ukrainian]. https://doi.org/10.15587/2519-4798.2017.100358
  16. Austin V, Crack PJ, Bozinovski S, Miller AA, Vlahos R. COPD and stroke: are systemic inflammation and oxidative stress the missing links? Clin Sci (Lond) 2016;130:1039–50. PMID: 27215677. PMCID: PMC4876483. https://doi.org/10.1042/CS20160043
  17. Zirlik A, Bode Ch, Gawaz M. Platelets, Haemostasis and Inflammation. Springer; 2017. 300 p. https://doi.org/10.1007/978-3-319-66224-4